Coronavirus: how do ‘spit tests’ work?
Thousands of volunteers to take part in mass trial of Covid-19 saliva tests from next week
The UK is moving a step closer to nationwide mass testing for Covid-19, as thousands of NHS workers and their families sign up to trial a new weekly saliva test.
Announcing the pilot scheme, which begins next week, Health Secretary Matt Hancock said that “saliva testing could potentially make it easier for people to take coronavirus tests at home”, with no need for swabs. “The trial will also help us learn if routine, at-home testing could pick up cases of the virus earlier,” he added.
More than 14,000 people in Southampton will take part in the first four-week phase of trials, growing to around 40,000 by the end of July. And if successful, the programme will be extended across the country.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Why does it matter?
Regular testing of the whole population, regardless of whether or not they feel unwell, would provide a much more detailed picture of how many people have the new coronavirus and whether it is retreating or spreading.
“It could potentially spot people who are infected but have no symptoms, yet still risk passing the disease on to others,” says the BBC. So-called asymptomatic transmission is otherwise all but impossible to detect, even with effective contact tracing.
According to random tests carried out by the Office for National Statistics, up to 70% of people carrying Covid-19 may be unaware that they are infected.
Early reports of new infection clusters “could be used to deal with local ‘flare-ups’ without the need for extensive lockdowns”, according to The Times.
Keith Godfrey, a Southampton University epidemiology professor working on the trial, says the initiative can “contribute to safely restoring economic activity within the city and region”.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
Health officials also hope that the new saliva tests will replace the “invasive, and sometimes painful, deep nasal and throat swab”, reports ITV News.
Inserting the swab “provokes coughing and spluttering, putting health workers - already working in close quarters with the testee - at even greater risk of the droplet-borne infection”, the broadcaster says.
The existing tests are also “believed to return false negative results in up to 30% of cases”, adds The Times.
How do the tests work?
“Saliva tests have looked promising for a while” but until now have not been widely used, says The Guardian.
The new test, made by West Sussex-based biomedical firm OptiGene, “looks for genetic material of the virus using a technique known as loop-mediated isothermal amplification”, explains the BBC.
Swab tests rely on a different testing system, which requires expensive lab equipment to raise and lower the temperature of the sample, encouraging the virus to grow to detectable levels.
By contrast, saliva test samples can be kept at a constant temperature throughout the assessment process, which is relatively simple, quick and cheap.
The new system has “an added advantage because saliva preserves the virus, so there is less urgency than with swabs, which have to be rushed to the lab”, says The Guardian.
How will the Southampton trial work?
Participants will spit into a plastic tube, “which they will either send off or have collected by Southampton University staff running the trial”, The Guardian reports. “They should get a result within 48 hours.”
Details of those who test positive will be sent to NHS contact tracers, who will notify anyone else who may have been infected.
“Ultimately, it might be possible to do the testing as well as the sampling at home and get results in under an hour,” says the BBC.
During the trial, the saliva tests “will be validated by comparing the results with traditional swab tests”, says The Times. “It will eventually include 40,000 people and provide the first concrete evidence of whether mass testing can be effective at scale in reducing infection rates.”
Who is eligible to enrol?
The first people invited to join will be staff in GP surgeries and their families, who will start weekly testing next week.
Over the following four weeks, “other essential key workers, university employees and their families” will also be invited to sign up, says The Guardian.
Swab tests will still be used in routine testing for NHS staff and anyone with symptoms who requests a test.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Why Bhutan hopes tourists will put a smile back on its face
Under The Radar The 'kingdom of happiness' is facing economic problems and unprecedented emigration
By Chas Newkey-Burden, The Week UK Published
-
7 beautiful towns to visit in Switzerland during the holidays
The Week Recommends Find bliss in these charming Swiss locales that blend the traditional with the modern
By Catherine Garcia, The Week US Published
-
The Week contest: Werewolf bill
Puzzles and Quizzes
By The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published